These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17583537)

  • 1. Towards automation of a valuable preclinical cardiac safety pharmacology assay: Evaluation of the effects of cardiac ion channel blockers on cardiac repolarisation in vitro.
    Lightbown ID; Johnson M; Davis A; Leaney J; Leishman DJ
    J Pharmacol Toxicol Methods; 2007; 56(2):194-202. PubMed ID: 17583537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of guinea-pig ventricular myocytes and dog Purkinje fibres for in vitro assessment of drug-induced delayed repolarization.
    Terrar DA; Wilson CM; Graham SG; Bryant SM; Heath BM
    J Pharmacol Toxicol Methods; 2007; 56(2):171-85. PubMed ID: 17596973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.
    Davie C; Pierre-Valentin J; Pollard C; Standen N; Mitcheson J; Alexander P; Thong B
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choice of cardiac tissue plays an important role in the evaluation of drug-induced prolongation of the QT interval in vitro in rabbit.
    Lu HR; Vlaminckx E; Teisman A; Gallacher DJ
    J Pharmacol Toxicol Methods; 2005; 52(1):90-105. PubMed ID: 15978848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The isolated rabbit heart and Purkinje fibers as models for identifying proarrhythmic liability.
    Roche M; Renauleaud C; Ballet V; Doubovetzky M; Guillon JM
    J Pharmacol Toxicol Methods; 2010; 61(3):238-50. PubMed ID: 20117224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for gender differences in electrophysiological properties of canine Purkinje fibres.
    Abi-Gerges N; Small BG; Lawrence CL; Hammond TG; Valentin JP; Pollard CE
    Br J Pharmacol; 2004 Aug; 142(8):1255-64. PubMed ID: 15265803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies.
    Ducroq J; Printemps R; Guilbot S; Gardette J; Salvetat C; Le Grand M
    J Pharmacol Toxicol Methods; 2007; 56(2):159-70. PubMed ID: 17604185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart.
    Bottino D; Penland RC; stamps A; Traebert M; Dumotier B; Georgiva A; Helmlinger G; Lett GS
    Prog Biophys Mol Biol; 2006; 90(1-3):414-43. PubMed ID: 16321428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimisation and validation of a medium-throughput electrophysiology-based hNav1.5 assay using IonWorks.
    Harmer AR; Abi-Gerges N; Easter A; Woods A; Lawrence CL; Small BG; Valentin JP; Pollard CE
    J Pharmacol Toxicol Methods; 2008; 57(1):30-41. PubMed ID: 17980627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choice of cardiac tissue in vitro plays an important role in assessing the risk of drug-induced cardiac arrhythmias in human: beyond QT prolongation.
    Lu HR; Vlaminckx E; Gallacher DJ
    J Pharmacol Toxicol Methods; 2008; 57(1):1-8. PubMed ID: 17964190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents.
    Gibson JK; Yue Y; Bronson J; Palmer C; Numann R
    J Pharmacol Toxicol Methods; 2014; 70(3):255-67. PubMed ID: 25219538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the guinea pig monophasic action potential (MAP) assay in predicting drug-induced delay of ventricular repolarisation using 12 clinically documented drugs.
    Kågström J; Sjögren EL; Ericson AC
    J Pharmacol Toxicol Methods; 2007; 56(2):186-93. PubMed ID: 17582787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate and concentration-dependent effects of UK-68,798, a potent new class III antiarrhythmic, on canine Purkinje fibre action potential duration and Vmax.
    Knilans TK; Lathrop DA; Nánási PP; Schwartz A; Varró A
    Br J Pharmacol; 1991 Jun; 103(2):1568-72. PubMed ID: 1884111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic effects of civamide (zucapsaicin) on canine cardiac tissue in vivo and in vitro.
    Arnar DO; Cai JJ; Lee HC; Martins JB
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):875-83. PubMed ID: 9869492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of amiodarone and dofetilide on the dispersion of repolarization between well-coupled ventricular and Purkinje fibers
    Árpádffy-Lovas T; Husti Z; Baczkó I; Varró A; Virág L
    Can J Physiol Pharmacol; 2021 Jan; 99(1):48-55. PubMed ID: 32692935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of combined use of dofetilide and verapamil on the action potential of papillary muscles in guinea pigs].
    Li ML; Zeng XR; Yang Y; Du JR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):834-8. PubMed ID: 19950594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the rabbit Purkinje fibre assay as an in vitro tool for assessing the risk of drug-induced torsades de pointes in humans.
    Aubert M; Osterwalder R; Wagner B; Parrilla I; Cavero I; Doessegger L; Ertel EA
    Drug Saf; 2006; 29(3):237-54. PubMed ID: 16524323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro preclinical cardiac assessment of tolterodine and terodiline: multiple factors predict the clinical experience.
    Martin RL; Su Z; Limberis JT; Palmatier JD; Cowart MD; Cox BF; Gintant GA
    J Cardiovasc Pharmacol; 2006 Nov; 48(5):199-206. PubMed ID: 17110801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A step towards characterisation of electrophysiological profile of torsadogenic drugs.
    Champeroux P; Ouillé A; Martel E; Fowler JS; Maurin A; Richard S; Le Guennec JY
    J Pharmacol Toxicol Methods; 2011; 63(3):269-78. PubMed ID: 21224008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological effects of ACC-9358, a novel class I antiarrhythmic agent, on isolated canine Purkinje fibers and ventricular muscle.
    Brown BS
    J Pharmacol Exp Ther; 1989 Feb; 248(2):552-8. PubMed ID: 2918472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.